The biological reactivity of calcium silicate composites: in vivo studies.
D000818:Animals; D001194:Asbestos / Q000009:adverse effects; D017632:Asbestos, Serpentine; D017610:Calcium Compounds; D004247:DNA / Q000378:metabolism; D004391:Dust; D005260:Female; D008168:Lung / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D011663:Pulmonary Surfactants / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D012119:Respiration; D017640:Silicates; D012824:Silicic Acid / Q000009:adverse effects*; D012822:Silicon Dioxide / Q000009:adverse effects*; D014025:Titanium / Q000009:adverse effects
D017632:Asbestos, Serpentine; D017610:Calcium Compounds; D004391:Dust; D011663:Pulmonary Surfactants; D017640:Silicates; D001194:Asbestos; D012824:Silicic Acid; C009495:titanium dioxide; D012313:RNA; D012822:Silicon Dioxide; D004247:DNA; D014025:Titanium; C031293:calcium silicate